Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Aug-22 5:04 PM View:  | Aprea Therapeutics, Inc. (APRE) | 28-Jul-22 | Grant | 24,300 | -- | -- | 113% 21.46K to 45.76K | |
| 07-Jun-22 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 03-Jun-22 | Payment of Exercise | 8,390 | $0.81 | $6,753.95 | (28%) 29.85K to 21.46K | |
| 14-Mar-22 5:03 PM View: | Aprea Therapeutics, Inc. (APRE) | 10-Mar-22 | Grant | 16,000 | -- | -- | 101% 15.84K to 31.84K | |
| 14-Mar-22 5:03 PM View: | Aprea Therapeutics, Inc. (APRE) | 10-Mar-22 | Payment of Exercise | 1,989 | $1.82 | $3,619.98 | (6%) 31.84K to 29.85K | |
| 01-Mar-22 5:02 PM View: | Aprea Therapeutics, Inc. (APRE) | 25-Feb-22 | Payment of Exercise | 1,326 | $1.74 | $2,307.24 | (8%) 17.17K to 15.84K | |
| 03-Dec-21 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 01-Dec-21 | Option Exercise | 27,500 | $0.92 | $25,300.00 | 160% 17.17K to 44.67K | |
| 03-Dec-21 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 01-Dec-21 | Market Option Sale (Planned) | 27,500 | $3.96 | $108,900.00 | (62%) 44.67K to 17.17K | |
| 03-Nov-21 5:34 PM View: | Aprea Therapeutics, Inc. (APRE) | 01-Nov-21 | Option Exercise | 27,500 | $0.92 | $25,300.00 | 160% 17.17K to 44.67K | |
| 03-Nov-21 5:34 PM View: | Aprea Therapeutics, Inc. (APRE) | 01-Nov-21 | Market Option Sale (Planned) | 27,500 | $5.00 | $137,500.00 | (62%) 44.67K to 17.17K | |
| 05-Oct-21 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 01-Oct-21 | Option Exercise | 27,500 | $0.92 | $25,300.00 | 160% 17.17K to 44.67K | |
| 05-Oct-21 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 01-Oct-21 | Market Option Sale (Planned) | 27,500 | $4.89 | $134,475.00 | (62%) 44.67K to 17.17K | |
| 22-Sep-21 10:00 PM View: | Aprea Therapeutics, Inc. (APRE) | 20-Sep-21 | Option Exercise | 27,500 | $0.92 | $25,300.00 | 122% 22.63K to 50.13K | |
| 22-Sep-21 10:00 PM View: | Aprea Therapeutics, Inc. (APRE) | 20-Sep-21 | Market Option Sale (Planned) | 27,500 | $4.97 | $136,721.00 | (55%) 50.13K to 22.63K | |
| 22-Sep-21 10:00 PM View: | Aprea Therapeutics, Inc. (APRE) | 20-Sep-21 | Market Sale (Planned) | 5,460 | $4.97 | $27,145.20 | (24%) 22.63K to 17.17K | |
| 14-Sep-21 5:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 10-Sep-21 | Payment of Exercise | 1,724 | $4.59 | $7,913.16 | (7%) 24.35K to 22.63K | 4% |
| 27-Aug-21 5:02 PM View: | Aprea Therapeutics, Inc. (APRE) | 25-Aug-21 | Payment of Exercise | 1,149 | $3.98 | $4,573.02 | (5%) 25.5K to 24.35K | (5%) |
| 11-Mar-21 5:30 PM View: | Aprea Therapeutics, Inc. (APRE) | 10-Mar-21 | Grant | 15,000 | -- | -- | 143% 10.5K to 25.5K | |
| 01-Mar-21 7:01 PM View: | Aprea Therapeutics, Inc. (APRE) | 25-Feb-21 | Grant | 10,000 | -- | -- | 2000% 0.5K to 10.5K | |
| 07-Oct-19 7:21 PM View: | Aprea Therapeutics, Inc. (APRE) | 07-Oct-19 | Purchase | 500 | $15.00 | $7,500.00 | 100% 0 to 0.5K |